KEGG   DRUG: Elastase ES
Entry
D04268                      Drug                                   

Name
Elastase ES;
Elaszym (TN)
Remark
Therapeutic category: 2189
Product: D04268<JP>
Efficacy
Antihyperlipidemic, Cholesterol catabolism enhancer, Lipoprotein lipase (LPL) activator, Lecithin-cholesterol acyltransferase (LCAT) activator
Target
LPL [HSA:4023] [KO:K01059]
LCAT [HSA:3931] [KO:K00650]
  Pathway
hsa00561  Glycerolipid metabolism
hsa03320  PPAR signaling pathway
hsa04979  Cholesterol metabolism
Interaction
Structure map
map07052  Antidyslipidemic agents
Brite
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  21  Cardiovascular agents
   218  Hyperlipidemia agents
    2189  Others
     D04268  Elastase ES
Target-based classification of drugs [BR:br08310]
 Enzymes
  Transferases (EC2)
   Acyltransferases
    LCAT
     D04268  Elastase ES <JP>
  Hydrolases (EC3)
   Carboxylic-ester hydrolases
    LPL
     D04268  Elastase ES <JP>
Other DBs
CAS: 9004-06-2
PubChem: 17398042
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system